comparemela.com

Latest Breaking News On - French big pharma sanofi - Page 1 : comparemela.com

MeiraGTx gifts last of gene therapy rights to J&J for $415M

MeiraGTx gifts last of gene therapy rights to J&J for $415M
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Sanofi taps singer Usher, others for Type 1 diabetes campaign

Sanofi taps singer Usher, others for Type 1 diabetes campaign
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Mexico ramping up COVID-19 trial work tapping Sanofi, China s shots in late-stage tests

(Rosewood Hotels & Resorts) French Big Pharma Sanofi, using its traditional vaccine approach, and Chinese biotech Walvax, using mRNA technology, are both set to start phase 3 trials in Mexico. Sanofi, which has a deal with GlaxoSmithKline and uses a recombinant protein-based technology, is set to kick-start its late-stage effort soon after Mexico s health regulator Cofepris gave it the all-clear this week, according to Reuters. So too will phase 3 trials begin from Walvax Biotechnology, which is using the same tech employed to good effect by BioNTech-Pfizer and Moderna, in a 6,000-person trial program. There is also a third native shot in the mix. Mexico s own so-called Patria vaccine is looking to start midstage trials but could nab an emergency use stamp this year.  

Sanofi, following Denali, pens gene therapy pact with Sirion Biotech

(Sanofi) French Big Pharma Sanofi is teaming up with Germany’s Sirion Biotech for its viral-vector-based gene delivery tech. The pair will work together on developing improved tissue-selective adeno-associated virus (AAV) vectors to tee up better gene therapy treatments. Targets have not yet been specifically mentioned, simply for “disorders affecting major human organs.” Financials of the deal were not made public. This comes two years after Sirion penned a similar pact with Denali Therapeutics, with other partners including Acucela and Orchard Therapeutics. Sanofi will work with Sirion and the German company’s partner at Heidelberg University Hospital, Dirk Grimm, to develop new and modified AAV capsids. The overall goal is to make safer, better gene therapies.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.